ESTRO 2024 - Abstract Book

S2210

Clinical - Upper GI

ESTRO 2024

Table showing frequency of disease status at last follow-up

Conclusion:

Definitive chemoradiation using VMAT technique for esophageal cancers appears to be a safe and effective treatment. VMAT also offers the advantage of treating using SIB.

Keywords: Definitive chemoradiation, esophageal cancer, VMAT

References:

Jimenez-Jimenez E, Font J, Mateos P, Romero F, Pardo J, Aymar N, Ortiz I, Vidal M, Sabater S. PO-1002: A comparison of outcomes using VMAT and 3DCRT in treatment of esophageal cancer. Radiotherapy and Oncology. 2016 Apr 1;119:S486.; Yang H, Feng C, Cai BN, Yang J, Liu HX, Ma L. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma. Diseases of the Esophagus. 2017 Feb 1;30(2).; M ü nch S, Aichmeier S, Hapfelmeier A, Duma MN, Oechsner M, Feith M, Combs SE, Habermehl D. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT. Strahlentherapie und Onkologie. 2016 Oct 1;192(10):722-9.; Yoshio K, Wakita A, Mitsuhashi T, Kitayama T, Hisazumi K, Inoue D, Tajiri N, Shiode T, Akaki S, Kanazawa S. Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Middle or Lower Esophageal Cancer Using Elective Nodal Irradiation: Comparison with 3D Conformal Radiotherapy. Acta Medica Okayama. 2019;73(3):247-57.; Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol [Internet]. 2002;20(5):1167 – 74. Available from:http://dx.doi.org/10.1200/JCO.2002.20.5.1167; Hulshof MCCM, Geijsen ED, Rozema T, Oppedijk V, Buijsen J, Neelis KJ, et al. Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO study). J Clin Oncol [Internet]. 2021;39(25):2816 – 24. Available from: http://dx.doi.org/10.1200/JCO.20.03697; Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, et al. Results of a phase 1/2 trial of chemoradiotherapy with simultaneous integrated boost of radiotherapy dose in unresectable locally advanced esophageal cancer. JAMA Oncol [Internet]. 2019;5(11):1597 – 604. Available from: http://dx.doi.org/10.1001/jamaoncol.2019.2809; Chang C-L, Tsai H-C, Lin W-C, Chang J-H, Hsu H-L, Chow J-M, et al. Dose escalation intensity-modulated radiotherapy – based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma. Radiother Oncol [Internet]. 2017;125(1):73 – 9. Available from: http://dx.doi.org/10.1016/j.radonc.2017.08.025

1845

Digital Poster

HCV as a favorable prognostic factor in HCC treated with SBRT: systematic review and meta-analysis

Lily Greenberg 1 , Rafi Kabarriti 2 , Justin Tang 2 , Andreas Kaubisch 3 , Chaoyuan Kuang 3 , Fernand Bteich 3 , Milan Kinkhabwala 4 , Chandan Guha 2 , Nitin Ohri 2